Role of the U.S. Food and Drug Administration in the Regulatory Management of Human Listeriosis in the United States
Abstract:From 1986 to 2006, the incidence of listeriosis in the United States dropped from approximately seven to three cases per million population, a reduction that most likely reflects the joint efforts of industry, government, consumers, and academia. Herein, we describe the U.S. Food and Drug Administration (FDA) strategy over the past three decades to combat listeriosis. Specifically, we discuss early actions taken to address outbreaks during the 1980s, policy decisions regarding the presence of Listeria monocytogenes in FDA-regulated foods, FDA compliance programs with L. monocytogenes components, enforcement actions to remove L. monocytogenes–contaminated products from the market (i.e., recalls) or to prevent entry of such products into the market (i.e., import detentions and refusals), research milestones, outreach and education efforts, and selected special projects. Evolving demographic trends in the United States may pose a challenge to further reduction of the incidence of listeriosis.
Document Type: Research Article
Affiliations: 1: Center for Food Safety and Applied Nutrition, U.S. Food and Drug Administration, College Park, Maryland 20740, USA 2: Office of the Commissioner, U.S. Food and Drug Administration, Rockville, Maryland 20857, USA
Publication date: 2008-06-01
- The Journal of Food Protection has moved to a new website. Please use http://jfoodprotection.org to access the Journal of Food Protection and Journal of Milk & Food Technology content on the new JFP site. Content on the IngentaConnect website will not be available after December 31, 2016.
- Information for Authors
- Submit a Paper
- Subscribe to this Title
- Membership Information
- Information for Advertisers
- Ingenta Connect is not responsible for the content or availability of external websites